# Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

> **NCT07107971** · NA · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 400 (estimated)

## Conditions studied

- Coronary Artery Disease
- Atheroscleroses
- Cardiovascular Disease
- Vulnerable Coronary Plaques
- Vulnerable Plaque
- Lipid-Rich Atherosclerosis of Coronary Artery
- Acute Coronary Syndromes (ACS)

## Interventions

- **DEVICE:** Paclitaxel-eluting balloon

## Key facts

- **NCT ID:** NCT07107971
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2028-01
- **Final completion:** 2033-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07107971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07107971, "Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07107971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*